会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • PACKET COALESCING
    • 包装包装
    • WO2006055494A1
    • 2006-05-26
    • PCT/US2005/041195
    • 2005-11-10
    • INTEL CORPORATIONMAKINENI, SrihariIYER, RavishankarMINTURN, DavidSEN, SujoyNEWELL, DonaldZHAO, Li
    • MAKINENI, SrihariIYER, RavishankarMINTURN, DavidSEN, SujoyNEWELL, DonaldZHAO, Li
    • H04L29/06
    • H04L45/74H04L49/20H04L69/16H04L69/161H04L69/166
    • In general, in one aspect, the disclosures describes a method that includes receiving multiple ingress Internet Protocol packets, each of the multiple ingress Internet Protocol packets having an Internet Protocol header and a Transmission Control Protocol segment having a Transmission Control Protocol header and a Transmission Control Protocol payload, where the multiple packets belonging to a same Transmission Control Protocol/Internet Protocol flow. The method also includes preparing an Internet Protocol packet having a single Internet Protocol header and a single Transmission Control Protocol segment having a single Transmission Control Protocol header and a single payload formed by a combination of the Transmission Control Protocol segment payloads of the multiple Internet Protocol packets. The method further includes generating a signal that causes receive processing of the Internet Protocol packet.
    • 一般来说,一方面,本公开内容描述了一种方法,其包括接收多个入口因特网协议分组,所述多个入口因特网协议分组中的每一个具有因特网协议报头和具有传输控制协议报头和传输控制的传输控制协议段 协议有效载荷,其中属于相同传输控制协议/因特网协议的多个分组流。 该方法还包括准备具有单个因特网协议报头的互联网协议分组和具有单个传输控制协议报头的单个传输控制协议段和由多个因特网协议分组的传输控制协议段有效载荷的组合形成的单个有效载荷 。 该方法还包括产生导致因特网协议分组的接收处理的信号。
    • 7. 发明申请
    • PYRAZOLOPYRIMIDINE DERIVATIVES AND USES AS ANTICANCER AGENTS
    • 吡唑并嘧啶衍生物和作为抗原剂的用途
    • WO2012097196A1
    • 2012-07-19
    • PCT/US2012/021144
    • 2012-01-12
    • ACEA BIOSCIENCES INC.MAO, LongZHAO, LiLIU, JiaWANG, XiaoboXU, Xiao
    • MAO, LongZHAO, LiLIU, JiaWANG, XiaoboXU, Xiao
    • C07D487/04A61K31/519A61P35/00
    • C07D487/04
    • Novel compounds having a fused pyrazolopyrimidine derivatives and related fused ring systems are disclosed. The compounds inhibit growth of a variety of types of cancer cells, and are thus useful for treating cancer. Pharmaceutical compositions, and methods of using these compounds and compositions to treat cancer and other diseases related to the dysregulation of kinase (such as Aurora A, Aurora B, Aurora C, cMet, JAK2, ROS1, but not limited to) pathways are disclosed. Efficacy of these compounds is demonstrated with a system for monitoring cell growth/migration, which shows they are potent inhibitors of growth and/or migration of cancer cells. Compositions comprising these compounds, and methods to use these compounds and compositions for treatment of cancers, are disclosed.
    • 公开了具有稠合吡唑并嘧啶衍生物和相关稠环体系的新型化合物。 这些化合物抑制多种类型的癌细胞的生长,因此可用于治疗癌症。 公开了药物组合物和使用这些化合物和组合物治疗与激酶失调相关的癌症和其它疾病(如Aurora A,Aurora B,Aurora C,cMet,JAK2,ROS1但不限于)途径的方法。 通过用于监测细胞生长/迁移的系统来证明这些化合物的功效,这表明它们是癌细胞的生长和/或迁移的有效抑制剂。 公开了包含这些化合物的组合物,以及使用这些化合物和用于治疗癌症的组合物的方法。